Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 11, 2014 07:05 ET | Source: MYOS Corporation

MYOS Corporation to Announce Third Quarter 2014 Financial Results and Host Conference Call on November 14, 2014

CEDAR KNOLLS, NJ--(Marketwired - Nov 11, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
November 04, 2014 08:05 ET | Source: MYOS Corporatation

MYOS Corporation Announces Positive Safety Data Demonstrating Fortetropin's(TM) Lack of Adverse Effect on Serum Lipids and Cholesterol Levels

CEDAR KNOLLS, NJ--(Marketwired - Nov 4, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...
October 30, 2014 07:35 ET | Source: MYOS Corporation

MYOS Corporation Announces Statistically Significant Top-Line Clinical Data Demonstrating Fortetropin's(TM) Anti-Inflammatory BioTherapeutic Properties

CEDAR KNOLLS, NJ--(Marketwired - Oct 30, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
October 02, 2014 08:05 ET | Source: MYOS Corporation

MYOS Corporation to Present Positive Clinical Data at 55th Annual Conference of the American College of Nutrition

CEDAR KNOLLS, NJ--(Marketwired - Oct 2, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...
September 18, 2014 07:35 ET | Source: MYOS Corporation

MYOS Corporation Announces Research Agreement With Human Metabolome Technologies America to Conduct Clinical Metabolomic Studies in Subjects Using Fortetropin(TM)

CEDAR KNOLLS, NJ--(Marketwired - Sep 18, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
September 04, 2014 07:35 ET | Source: MYOS Corporation

MYOS Corporation to Present at the Rodman & Renshaw 16th Annual Global Investment Conference on September 10, 2014

CEDAR KNOLLS, NJ--(Marketwired - Sep 4, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...
August 14, 2014 06:45 ET | Source: MYOS Corporation

MYOS Corporation Reports 2014 Second Quarter Results

CEDAR KNOLLS, NJ--(Marketwired - Aug 14, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...
August 07, 2014 08:05 ET | Source: MYOS Corporation

MYOS Corporation to Announce Second Quarter 2014 Financial Results on August 14, 2014

CEDAR KNOLLS, NJ--(Marketwired - Aug 7, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...
August 06, 2014 08:05 ET | Source: MYOS Corporation

MYOS Corporation Reports Additional Clinical Data on the Impact of Fortetropin on Lean Body Mass, Fat Mass and Muscle Size in Male Subjects

CEDAR KNOLLS, NJ--(Marketwired - Aug 6, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development...
July 30, 2014 08:04 ET | Source: MYOS Corporation

MYOS Corporation Announces Appointment of Douglas Weekes as Chief Commercial Officer

CEDAR KNOLLS, NJ--(Marketwired - Jul 30, 2014) - MYOS Corporation ("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery,...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right